Breaking News

Eisai to Relocate U.S. HQ in New Jersey

Will make the ON3 campus in Nutley its U.S. headquarters.

By: Contract Pharma

Contract Pharma Staff

Eisai Inc., an oncology- and neurology-focused pharmaceutical company and the U.S. subsidiary of Eisai Co., Ltd., based in Tokyo, Japan, has unveiled plans to relocate its New Jersey-based headquarters to the technologically-advanced and cutting-edge ON3 property in Nutley, NJ. The company plans to transfer up to 1,200 Eisai corporate staff and research and development functions from Woodcliff Lake to Nutley in late 2021.   “Eisai is a human health care company. This ON3 Eisai workplace wi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters